Design Therapeutics plans to initiate patient dosing for DT-818, a potential treatment for Myotonic Dystrophy Type-1, in the first half of 2026. The company has obtained ex-US regulatory clearance and is developing gene-targeted therapies for various genetic diseases.

CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conference on Wednesday, May 15, 2024, at 11:30 a.m. ET in New York.

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. FTC Solar The Trade: FTC Solar, Inc. (NASDAQ: FTCI) Director Ahmad R Chatila acquired a total of 92,600 shares an average price of $0.55. To acquire these shares, it cost around $50,930. What’s Happening: On March 13, FTC ...

New Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by Year-end 2024 to Start Patient Trials in 2025

CARLSBAD, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that the company will host a conference call and live webcast on Tuesday, March 19, 2024, at 4:30 p.m. ET to discuss its fourth quarter and full year 2023 financial results and provide a comprehensive portfolio update.

Design Therapeutics, Inc. (DSGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Seasoned Biotech Executive Pratik Shah Appointed as Chief Executive Officer to Lead Company Turnaround

The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Carmell Therapeutics The Trade: Carmell Therapeutics Corporation (NASDAQ: CTCX) President and CEO Randolph W Hubbell acquired a total of 2,750 shares an average price of $3.67. To acquire these shares, it cost around $10,091. What’s Happening: Carmell Therapeutics announced a merger with Axoloti Biologix. What Carmell Therapeutics Does: Carmell Therapeutics Corp is a regenerative medicine biotech company focused on leveraging our core platform technology, Plasma-based ...

RBC Capital Market downgraded Design Therapeutics Inc (NASDAQ: DSGN) from Outperform to Sector Perform with a price target of $7, down from $23. The company reported initial results from the company's Phase 1 multiple-ascending dose clinical trial of DT-216 in patients with Friedrich ataxia.  The company also announced plans to reformulate its Friedreich ataxia drug following injection site reactions in a Phase 1 study. Analysts Leonid Timashev and Brian Abrahams see signs of activity from DT-216 that confirm that the geneTAC ...Full story available on Benzinga.com

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The S&P 500, also fell, dropping, 0.87% to 4,450.59. Check This Out: LyondellBasell, Dropbox And 2 Other Stocks Insiders Are Selling   Leading and Lagging Sectors Health care shares fell by just 0.2% on Tuesday. In trading on Tuesday, energy shares dipped by 2.4%.   Top Headline The Home Depot, Inc. (NYSE: HD) reported better-than-expected results for its second quarter. The company posted a second-quarter FY23 sales decline of 2% year-on-year to $42.92 billion, beating the analyst consensus of $42.25 billion. EPS of $4.65 beat the analyst consensus of $4.46. The board of directors also authorized a new $15 billion share repurchase program effective August 15, 2023, replacing its previous authorization. Equities Trading UP Delcath Systems, Inc. (NASDAQ: DCTH) shares shot up 88% to $5.88 after the company announced FDA approval of HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Shares of Novo Integrated Sciences, Inc. (NASDAQ: NVOS) got a boost, shooting 56% to $0.1107 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. Siyata Mobile Inc. (NASDAQ: SYTA) shares were also up, gaining 32% to $4.3872 following upbeat quarterly sales.   Equities Trading DOWN F45 Training Holdings Inc. (NYSE:

The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. Delcath Systems, Inc. (NASDAQ: DCTH) shares jumped 85.3% to $5.78 after the company announced FDA approval of HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Tiziana Life Sciences Ltd (NASDAQ: TLSA) surged 40% to $0.8720 after the company announced FDA IND clearance of intranasal foralumab to be studied in Alzheimer's disease. G Medical Innovations Holdings Ltd (NASDAQ: GMVD) shares gained 36.3% to $0.2590 after falling over 7% on Monday. Siyata Mobile Inc. (NASDAQ: SYTA) shares rose 28.3% to $4.2599 following upbeat quarterly sales. Wearable Devices Ltd. (NASDAQ: WLDS) jumped 23% to $1.40 after the company completed first manufacturing batch of the Mudra Band for Apple Watch. Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 22.4% to $2.6812 after the company posted strong quarterly sales and announced leadership changes. The Arena Group Holdings, Inc. (NYSE: AREN) shares gained 19.5% to $4.0399 after the company announced it signed a binding letter of intent to combine with Bridge Media Networks. Pharvaris N.V. (NASDAQ: PHVS) gained 19.4% to $22.00 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $34. LL Flooring Holdings, Inc. (NYSE: LL) shares climbed 18.9% to $4.46 after the company’s board announced exploration of strategic alternatives, including a sale. Paysafe Limited (NYSE: PSFE) gained 18.9% to $14.05. Paysafe reported second-quarter FY23 revenue growth of 6% year-over-year to $402.338 million, beating the consensus of $394.16 million. Taylor Devices, Inc. (NASDAQ: TAYD) rose 18.6% to $22.01 following fourth-quarter results. T2 Biosystems, Inc. (NASDAQ: TTOO) shares gained 18% to $0.46 after jumping 15% on Monday. Fifth Wall Acquisition Corp. III (NASDAQ: FWAC) climbed 17.7% to $9.00. ENDRA ...